about
A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesisNORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinomaCDK6 as a key regulator of hematopoietic and leukemic stem cell activationBiochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxelSPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers.Lung cancer: from single-gene methylation to methylome profiling.EVI1 promotes tumor growth via transcriptional repression of MS4A3.Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells.5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand.Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers.Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion.Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia.Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.DNA methylation of miRNA-encoding genes in non-small cell lung cancer patients.c-JUN promotes BCR-ABL-induced lymphoid leukemia by inhibiting methylation of the 5' region of Cdk6.Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapySERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine TreatmentCDK6 Antagonizes p53-Induced Responses during TumorigenesisCGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid LeukemiaSTAT5BN642H drives transformation of NKT cells: a novel mouse model for CD56+ T-LGL leukemiaSOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness
P50
Q28296641-F06914BC-9CD1-42DA-ABC4-5E482836A334Q28300321-AE1B3954-BBF8-4F28-9A07-05649E76769CQ28587749-1E28F863-2420-4C44-B2DC-AA258DAC50E9Q33884827-282CCC84-B554-465A-87FB-2FED96DD3186Q37589062-C147C09C-9B06-4CB6-AF8B-AF407CD22AADQ37680724-2285364A-2E9E-465F-9939-33D2446018D2Q38299701-BC32B501-8D25-481C-99BE-1F63A16CDDF5Q38870822-8789C2B1-B19D-4B0F-B213-AF1EB9825BD4Q38944648-374A62BA-F4B8-4C04-89CF-E319E19598E0Q39375748-472C2A31-F2D2-40FA-A12D-60307F7AA725Q39405435-19606790-67A0-4060-B5B4-1335469B2BA9Q40109216-03C3F644-8B5F-4753-8BAD-858200130F71Q40137544-E8E0011E-8F45-4452-99C0-7462C0761439Q40177736-389084A1-6124-4122-ABDC-BF21D8127002Q40912349-DD39B7DA-93E2-4EC5-BD03-56F59FB0DA0BQ42330162-86B5D728-F6F6-4127-BD7A-B20F41DB7951Q45906493-5EC757B4-27F3-4982-A1C7-C21FD42EAA81Q51416252-D4E7C11F-BCF6-440F-8942-1898A91EDACBQ53269697-EBAE4906-E391-4DB5-AE17-3C97A6872041Q57075545-64FDE210-155D-48B9-98C4-977247792108Q58711248-CFFD688B-1571-4A1C-B29D-584C0AEDD6E4Q63383536-0AE8C288-8BC0-4D7D-9AF2-B32E3D491A7BQ91399863-F9D9A143-1141-4CAA-B96D-500F38E7A3AAQ92987262-95EE5E4B-A49C-4018-B60A-D899A96BCAFDQ93000744-FC7018A1-8440-4C58-B43C-C5E40DD4CC2C
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Gerwin Heller
@ast
Gerwin Heller
@en
Gerwin Heller
@es
Gerwin Heller
@nl
type
label
Gerwin Heller
@ast
Gerwin Heller
@en
Gerwin Heller
@es
Gerwin Heller
@nl
altLabel
Heller G
@en
prefLabel
Gerwin Heller
@ast
Gerwin Heller
@en
Gerwin Heller
@es
Gerwin Heller
@nl
P1053
E-6521-2011
P106
P31
P496
0000-0001-8742-5631